What is the scope of this report?

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry. Read More

Which segments covered in this report?

Market is segmented by Types, Applications, Technology, End-use Industries, and Regions. Read More

What are the key factors covered in this report?

The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions. Read More

Oncology Pharmaceuticals Market in India 2014

Q: Does this report offer customization?

Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs. Read More

Report Code : 250857
Industry : Healthcare and Pharmaceuticals
Published On : Sep 2014
Pages : 90
Publisher : Netscribes
Format:

Netscribes' latest market research report titled Oncology Pharmaceutical Market in India 2014 highlights the analysis of the drivers and explains the factors for growth of the industry. Increasing number of cancer cases are the key drivers of this market. Lung, stomach, colon and breast cancer cause the maximum number of cancer deaths each year. Pharmaceutical companies are progressively increasing R&D expenditure on cancer vaccines. The growing number of patients seeking treatment for cancer has made hospitals realize that cancer treatment is an important area for growth. Gleevec, Mabthera, Iressa, Avastin, Grafeel, Soliris and Herceptin are the top selling cancer drugs in the Indian market.

Alternative therapies such as cancer gene therapy and cancer cell therapy are increasingly becoming popular in cases where conventional therapies have failed. Combination therapies are being increasingly used in cancer treatments. Some challenges faced by the industry are the internal competition between large pharmaceutical companies. Another challenge is the penetration of Oncological drugs in rural areas which is very low. Various government initiatives have been undertaken to reduce the drug prices and various tax reforms and control programs are promoting the growth of the market as well. Manufacture of generic oncology drugs will help the pharmaceutical manufacturer gain a competitive advantage over others in a highly competitive pharma market. Companies should focus on development of new molecules in order to prolong the longevity of a blockbuster drug in the market.

Slide 1: Executive Summary

Macroeconomic Indicators
Slide 2: GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (Jul 2013 - Dec 2013)
Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013 - Jul 2013), Exchange Rate: Half Yearly (Oct 2013 - Mar 2014)
Slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2010-11, 2011-12, 2012-13, 2013-14), FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13)

Introduction
Slide 5-6: Types of Chemotherapy drugs

Market Overview
Slide 7-9: Global Oncology Pharmaceutical Market - Overview, Market Size & Growth (2013-2018e), Indian Oncology Pharmaceutical Market - Overview, Market Size & Growth (2013-2018e), Regions with high cancer prevalence, Top 5 cancer's in India

Export-Import
Slide 10-11: Region wise Exports, Total Exports, Region wise Imports, Total Imports

Value Chain
Slide 12-13: Market Value Chain Analysis

Drivers & Challenges
Slide 14: Drivers and Challenges - Summary
Slide 15-19: Drivers
Slide 20-22: Challenges

Government Initiatives
Slide 23: Government Initiatives - Summary
Slide 24: Helping the Market to grow
Slide 25: National List of Essential Medicines (NLEM), Jan Aushadhi Stores (JAS)
Slide 26-27: cancer awareness programmes
Slide 28: Reduction in Excise Duties

Regulations
Slide 29: Licensing and registration of pharmaceuticals
Slide 30: Various other regulatory frameworks
Slide 31-33: Patent Approvals

Competitive Landscape
Slide 34: Porter's Five Forces Analysis
Slide 35: Public Trading Comparables, Top 3 Companies
Slide 36-38: Competitive Benchmarking, Key Ratios of Top 3 Companies - Operational Basis (FY 2013)
Slide 39: Competitive Benchmarking, Key Ratios of Top 3 Companies - Financial Basis (FY 2013)
Slide 40-75: Major Public Players
Slide 76-85: major Private Players

Recent Developments
Slide 86-87: Recent Developments

Strategic Recommendation
Slide 88: Strategic recommendation

Appendix
Slide 89: Key Ratios Description
Slide 90: Sources of Information

Asia Pacific Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034.

Price : US$ 3450	Date : Oct 2024
Category : Healthcare and Pharmaceuticals	Pages : 191

Europe Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034.

Price : US$ 3450	Date : Oct 2024
Category : Healthcare and Pharmaceuticals	Pages : 196

North America Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034.

Price : US$ 3450	Date : Oct 2024
Category : Healthcare and Pharmaceuticals	Pages : 194

Global Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034.

Price : US$ 3750	Date : Oct 2024
Category : Healthcare and Pharmaceuticals	Pages : 205

Pharmaceuticals Contract Testing Service Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)

Price : US$ 3500	Date : Jul 2024
Category : Healthcare and Pharmaceuticals	Pages : 146

Choose License Type

Happy To Assist You

We will be happy to help you find what you need. Please call us or write to us:

Email
sales@worldwidemarketreports.com
United States Of America

+1-415-871-0703
United Kingdom

+44-203-289-4040
Australia

+61-2-4786-0457
INDIA

+91-848-285-0837

Frequently Asked Questions

What does this report covers?

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.

Does this report estimates the current market size?

The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.

Does the report provides Market Size in terms of – Value (US$ Mn) and Volume (Thousands Units)?

The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).

What are the key segments offered in this report?

Market is segmented by:

Which market dynamics covered in this report?

The report share key insights on the following:

It helps the businesses in making investments decisions.

Does this report offer customization?

Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.